The Tuberculosis Diagnostics by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Tuberculosis Diagnostics Market:
https://www.thebusinessresearchcompany.com/report/tuberculosis-diagnostics-global-market-report
According to The Business Research Company’s Tuberculosis Diagnostics, The tuberculosis diagnostics market size has grown strongly in recent years. It will grow from $2.11 billion in 2023 to $2.27 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to rise in the incidence of tuberculosis, increased healthcare expenditure, growth in the number of healthcare facilities and the rise in the adoption of nucleic acid testing.
The tuberculosis diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.02 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to strong government support, the increasing fda approvals for tuberculosis diagnostics, the increasing research and development (r&d) activities and the emergence of drug-resistant tb. Major trends in the forecast period include focus on next generation sequencing (ngs) platform for tb diagnostics, product innovations, t cell tests for tb infection, artificial intelligence (ai)-based tuberculosis diagnostics, use of portable devices and collaborations between governments and manufacturers.
The rise in the incidence of tuberculosis is driving the demand for the tuberculosis diagnostics market going forward. Tuberculosis is an infectious disease that affects the lungs and can be severe. Tuberculosis is spread through coughing and sneezing, releasing tiny germs into the air. Tuberculosis diagnostics aid in patient detection, with earlier diagnosis and detection of diseases. For instance, in March 2022, in the weekly report of the Centers for Disease Control and Prevention, a US-based national public health agency, tuberculosis infections in the United States increased by 9.4% in 2021, with a total of 7,860 TB cases were reported in 2021, an increase from 7,173 cases in 2020. Therefore, the rise in the incidence of tuberculosis is driving the growth of the tuberculosis diagnostics market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=8165&type=smp
The tuberculosis diagnostics market covered in this report is segmented –
1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types
2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis
3) By End-User: Hospitals And Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics And Research Facilities
Technological innovations are the key trend gaining popularity in the tuberculosis diagnostics market. Major companies operating in the market are introducing new technologies, such as advanced point-of-care (POC) diagnostic methods that work on AI technology to sustain their position in the market. For instance, in August 2022, Fujifilm, a Japan-based company engaged in the manufacturing of medical imaging devices, partnered with Qure.ai, a US-based company engaged in the development of AI-enabled medical imaging solutions, and launched an advanced point-of-care (POC) diagnostic method. A battery-powered X-ray machine is used in this method for tuberculosis diagnosis. With the help of artificial intelligence, algorithms help in effective testing programs, offering ultra-portability, high accuracy, and efficient point-of-care diagnostic solutions.
The tuberculosis diagnostics market report table of contents includes:
1. Executive Summary
2. Tuberculosis Diagnostics Market Characteristics
3. Tuberculosis Diagnostics Market Trends And Strategies
4. Tuberculosis Diagnostics Market - Macro Economic Scenario
5. Global Tuberculosis Diagnostics Market Size and Growth
...................
31. Tuberculosis Diagnostics Market Other Major And Innovative Companies
32. Global Tuberculosis Diagnostics Market Competitive Benchmarking
33. Global Tuberculosis Diagnostics Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Tuberculosis Diagnostics Market
35. Tuberculosis Diagnostics Market Future Outlook and Potential Analysis
Read Related Topics:
https://goodprnews.com/laser-weapon-systems-global-market-report/
https://goodprnews.com/lawful-interception-global-market-size/
https://goodprnews.com/leak-detection-and-repair-global-market-size/
https://topprnews.com/laser-weapon-systems-global-market-share/
https://topprnews.com/lawful-interception-global-market-2024-share/
https://topprnews.com/leak-detection-and-repair-global-market-share/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Market Overview-The global tuberculosis (TB) diagnostics market size is projected to witness remarkable growth in the forthcoming years.
Fortune Business Insights™ has presented this information in an upcoming report, titled, “Tuberculosis (TB) Diagnostics Market, 2021-2028”.The tuberculosis (TB) diagnostics market is projected to gain steep momentum due to several reasons.
It has negatively impacted tuberculosis (TB) diagnostics market.
Additionally, the shifting focus of the healthcare sector on treating coronavirus-infected patients has stagnated market growth.
On the basis of end-user, the market is fragmented into diagnostic centers, specialty clinics, and hospitals.
Geographically, the market is classified into Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa.Report Coverage-The report is devised using an innovative research methodology that follows top-down and bottom-up approaches to market research.The report provides vital information on different market segments; test type, end-user, etc.The report assimilates Porters’ Five Forces Analysis for an unerring market prediction.The report provides valuable insights into the regulatory scenarios of the market.The report evaluates the impact of the COVID-19 pandemic and suggests future growth strategies.Drivers & Restraints-Rising Worldwide TB Prevalence to Augment Market GrowthThe increasing numbers of tuberculosis cases worldwide are expected to bolster global tuberculosis (TB) diagnostics market growth.
Global Tuberculosis Diagnostics Market is anticipated to reach USD 3.1 billion by 2024 owing to the introduction of enhanced diagnostic techniques like serological methods, IGRA (Interferon-gamma Release Assay), and nucleic acid testing.
Tuberculosis is an infectious disorder caused by mycobacterium tuberculosis bacteria that attacks the lungs.
The disorder can also spread to the other parts of the body like spine and brain.
Depending on the type of tuberculosis suspected in the body, several tests are available for the diagnosis.Tuberculosis diagnostics industry is influenced by factors like quick results and improved accuracy, increasing government initiatives, growing elderly population and rising need for POC in healthcare sector.
However, tuberculosis diagnostics market is restrained by significant cost of tuberculosis diagnosis and lack of awareness in patients.
Additionally, the increasing burden of tuberculosis is the major factor expected to bring greater opportunities in tuberculosis diagnostics industry.Download Free Sample Report @ https://www.millioninsights.com/industry-reports/tuberculosis-diagnostics-market/request-sampleTuberculosis diagnostics market is categorized on the basis of test type, end user, and geography.
Tuberculosis Diagnostics Market is anticipated to reach USD 3.1 billion by 2024 owing to the introduction of enhanced diagnostic techniques like serological methods, IGRA (Interferon-gamma Release Assay), and nucleic acid testing.
Tuberculosis is an infectious disorder caused by mycobacterium tuberculosis bacteria that attacks the lungs.
The disorder can also spread to the other parts of the body like spine and brain.
Request a Sample PDF Copy of This Report @ https://www.millioninsights.com/industry-reports/tuberculosis-diagnostics-market/request-sample The key driving factors responsible for the growth of Tuberculosis Diagnostics market : Tuberculosis diagnostics industry is influenced by factors like quick results and improved accuracy, increasing government initiatives, growing elderly population and rising need for POC in healthcare sector.
However, tuberculosis diagnostics market is restrained by significant cost of tuberculosis diagnosis and lack of awareness in patients.
Tuberculosis diagnostics market is categorized on the basis of test type, end user, and geography.
